Concepts (218)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| HIV Infections | 29 | 2018 | 1018 | 4.590 |
Why?
|
| Sexually Transmitted Diseases | 12 | 2014 | 114 | 1.780 |
Why?
|
| Patient Acceptance of Health Care | 9 | 2017 | 314 | 1.480 |
Why?
|
| South Africa | 17 | 2018 | 63 | 1.460 |
Why?
|
| Rural Population | 10 | 2018 | 191 | 1.380 |
Why?
|
| Reagent Kits, Diagnostic | 3 | 2016 | 39 | 1.300 |
Why?
|
| Community Networks | 5 | 2017 | 37 | 1.020 |
Why?
|
| Brazil | 19 | 2015 | 93 | 0.990 |
Why?
|
| Self Care | 4 | 2016 | 188 | 0.980 |
Why?
|
| Sexual Behavior | 8 | 2015 | 340 | 0.940 |
Why?
|
| Sexual Partners | 7 | 2018 | 107 | 0.860 |
Why?
|
| Social Environment | 5 | 2013 | 199 | 0.820 |
Why?
|
| Homosexuality, Male | 4 | 2016 | 342 | 0.820 |
Why?
|
| Social Stigma | 4 | 2017 | 95 | 0.810 |
Why?
|
| AIDS Serodiagnosis | 4 | 2017 | 26 | 0.780 |
Why?
|
| Unsafe Sex | 4 | 2012 | 46 | 0.750 |
Why?
|
| Sex Workers | 2 | 2013 | 15 | 0.740 |
Why?
|
| Condoms | 5 | 2015 | 41 | 0.730 |
Why?
|
| Health Services Accessibility | 3 | 2016 | 532 | 0.700 |
Why?
|
| Mass Screening | 4 | 2017 | 745 | 0.680 |
Why?
|
| Health Promotion | 4 | 2017 | 176 | 0.680 |
Why?
|
| Community Health Services | 3 | 2017 | 81 | 0.680 |
Why?
|
| Program Evaluation | 2 | 2014 | 346 | 0.660 |
Why?
|
| Sex Work | 5 | 2012 | 13 | 0.620 |
Why?
|
| Interviews as Topic | 9 | 2017 | 387 | 0.590 |
Why?
|
| Risk-Taking | 5 | 2018 | 159 | 0.580 |
Why?
|
| Adolescent | 23 | 2018 | 10080 | 0.540 |
Why?
|
| Health Knowledge, Attitudes, Practice | 6 | 2017 | 601 | 0.530 |
Why?
|
| Counseling | 3 | 2017 | 191 | 0.490 |
Why?
|
| Behavior Rating Scale | 1 | 2016 | 5 | 0.480 |
Why?
|
| Adult | 32 | 2018 | 29539 | 0.480 |
Why?
|
| Community Participation | 1 | 2016 | 40 | 0.460 |
Why?
|
| Anti-Retroviral Agents | 1 | 2016 | 36 | 0.460 |
Why?
|
| Young Adult | 20 | 2017 | 7507 | 0.460 |
Why?
|
| Text Messaging | 1 | 2016 | 36 | 0.460 |
Why?
|
| Continuity of Patient Care | 2 | 2017 | 179 | 0.450 |
Why?
|
| Clinical Protocols | 1 | 2016 | 162 | 0.450 |
Why?
|
| Patient Dropouts | 1 | 2015 | 33 | 0.450 |
Why?
|
| Male | 31 | 2018 | 47076 | 0.440 |
Why?
|
| Antiretroviral Therapy, Highly Active | 1 | 2015 | 73 | 0.440 |
Why?
|
| Bisexuality | 1 | 2015 | 36 | 0.440 |
Why?
|
| Ambulatory Care Facilities | 1 | 2015 | 120 | 0.420 |
Why?
|
| Psychometrics | 1 | 2016 | 356 | 0.410 |
Why?
|
| Preventive Health Services | 1 | 2014 | 38 | 0.410 |
Why?
|
| Transgender Persons | 1 | 2016 | 121 | 0.410 |
Why?
|
| Humans | 48 | 2018 | 98080 | 0.400 |
Why?
|
| Masculinity | 1 | 2013 | 18 | 0.400 |
Why?
|
| Domestic Violence | 1 | 2013 | 25 | 0.390 |
Why?
|
| Surveys and Questionnaires | 9 | 2017 | 3022 | 0.390 |
Why?
|
| Social Participation | 1 | 2013 | 17 | 0.380 |
Why?
|
| Adolescent Health Services | 1 | 2012 | 14 | 0.360 |
Why?
|
| Health Personnel | 1 | 2015 | 257 | 0.360 |
Why?
|
| San Francisco | 5 | 2016 | 27 | 0.360 |
Why?
|
| Reproductive Health Services | 1 | 2012 | 20 | 0.360 |
Why?
|
| Self-Examination | 2 | 2013 | 5 | 0.360 |
Why?
|
| Socioeconomic Factors | 9 | 2016 | 663 | 0.350 |
Why?
|
| Patient Compliance | 2 | 2017 | 245 | 0.340 |
Why?
|
| Attitude | 1 | 2012 | 133 | 0.330 |
Why?
|
| Female | 29 | 2018 | 51536 | 0.330 |
Why?
|
| Patient Preference | 1 | 2012 | 136 | 0.320 |
Why?
|
| Global Health | 2 | 2013 | 215 | 0.310 |
Why?
|
| Models, Statistical | 2 | 2010 | 601 | 0.300 |
Why?
|
| Probability | 1 | 2010 | 356 | 0.300 |
Why?
|
| Papillomaviridae | 1 | 2010 | 184 | 0.280 |
Why?
|
| Substance-Related Disorders | 1 | 2013 | 470 | 0.270 |
Why?
|
| Focus Groups | 3 | 2016 | 214 | 0.270 |
Why?
|
| Motor Vehicles | 1 | 2007 | 20 | 0.260 |
Why?
|
| Health Services Administration | 1 | 2007 | 2 | 0.260 |
Why?
|
| Vaginal Smears | 1 | 2007 | 71 | 0.250 |
Why?
|
| Health Services | 1 | 2007 | 55 | 0.250 |
Why?
|
| Travel | 1 | 2007 | 77 | 0.250 |
Why?
|
| Occupational Diseases | 1 | 2007 | 58 | 0.250 |
Why?
|
| International Cooperation | 1 | 2007 | 132 | 0.250 |
Why?
|
| Uterine Cervical Neoplasms | 1 | 2010 | 323 | 0.240 |
Why?
|
| Papillomavirus Infections | 1 | 2010 | 310 | 0.240 |
Why?
|
| Cross-Sectional Studies | 7 | 2017 | 2037 | 0.240 |
Why?
|
| Pilot Projects | 4 | 2016 | 977 | 0.240 |
Why?
|
| Qualitative Research | 3 | 2017 | 414 | 0.220 |
Why?
|
| Middle Aged | 12 | 2017 | 29428 | 0.220 |
Why?
|
| Herpes Genitalis | 2 | 2015 | 8 | 0.200 |
Why?
|
| Quality Assurance, Health Care | 2 | 2015 | 228 | 0.200 |
Why?
|
| Residence Characteristics | 4 | 2015 | 224 | 0.200 |
Why?
|
| Prejudice | 2 | 2016 | 51 | 0.180 |
Why?
|
| Sex Factors | 2 | 2017 | 1138 | 0.180 |
Why?
|
| Alcohol Drinking | 2 | 2015 | 301 | 0.180 |
Why?
|
| Cluster Analysis | 2 | 2017 | 401 | 0.170 |
Why?
|
| Pain | 1 | 2003 | 416 | 0.170 |
Why?
|
| HIV-1 | 2 | 2014 | 179 | 0.160 |
Why?
|
| Trichomonas vaginalis | 2 | 2013 | 3 | 0.160 |
Why?
|
| Risk Factors | 7 | 2016 | 6233 | 0.160 |
Why?
|
| Leiomyoma | 1 | 2003 | 225 | 0.150 |
Why?
|
| Perception | 2 | 2017 | 187 | 0.150 |
Why?
|
| Uterine Neoplasms | 1 | 2003 | 289 | 0.150 |
Why?
|
| Early Diagnosis | 2 | 2017 | 141 | 0.140 |
Why?
|
| Herpesvirus 2, Human | 2 | 2015 | 21 | 0.130 |
Why?
|
| Intimate Partner Violence | 1 | 2018 | 36 | 0.130 |
Why?
|
| Poverty | 2 | 2012 | 215 | 0.130 |
Why?
|
| Prevalence | 5 | 2018 | 1384 | 0.130 |
Why?
|
| Rural Health | 1 | 2017 | 18 | 0.130 |
Why?
|
| HIV Seroprevalence | 1 | 2016 | 9 | 0.120 |
Why?
|
| Feasibility Studies | 2 | 2016 | 801 | 0.120 |
Why?
|
| CD4 Lymphocyte Count | 1 | 2016 | 75 | 0.120 |
Why?
|
| Polymerase Chain Reaction | 2 | 2009 | 895 | 0.120 |
Why?
|
| Public Facilities | 1 | 2016 | 1 | 0.120 |
Why?
|
| Alcoholism | 1 | 2018 | 198 | 0.120 |
Why?
|
| Attitude to Health | 1 | 2017 | 217 | 0.120 |
Why?
|
| Medication Adherence | 1 | 2017 | 130 | 0.120 |
Why?
|
| Poverty Areas | 2 | 2014 | 37 | 0.120 |
Why?
|
| Social Control, Informal | 1 | 2015 | 7 | 0.110 |
Why?
|
| Sample Size | 1 | 2016 | 130 | 0.110 |
Why?
|
| Costs and Cost Analysis | 1 | 2016 | 155 | 0.110 |
Why?
|
| Alcoholic Beverages | 1 | 2015 | 12 | 0.110 |
Why?
|
| Life Change Events | 1 | 2015 | 49 | 0.110 |
Why?
|
| South America | 1 | 2015 | 38 | 0.110 |
Why?
|
| Social Perception | 1 | 2016 | 93 | 0.110 |
Why?
|
| Laboratory Proficiency Testing | 1 | 2014 | 5 | 0.110 |
Why?
|
| Social Support | 2 | 2015 | 246 | 0.110 |
Why?
|
| Blood | 1 | 2014 | 68 | 0.110 |
Why?
|
| Program Development | 1 | 2015 | 141 | 0.110 |
Why?
|
| Shame | 1 | 2014 | 4 | 0.110 |
Why?
|
| Stress, Psychological | 1 | 2018 | 383 | 0.110 |
Why?
|
| North America | 1 | 2015 | 210 | 0.110 |
Why?
|
| Data Collection | 1 | 2016 | 376 | 0.110 |
Why?
|
| Urban Population | 2 | 2014 | 246 | 0.100 |
Why?
|
| Health Surveys | 3 | 2014 | 254 | 0.100 |
Why?
|
| Viral Load | 1 | 2014 | 161 | 0.100 |
Why?
|
| Regression Analysis | 3 | 2010 | 578 | 0.100 |
Why?
|
| Veterans | 1 | 2015 | 119 | 0.100 |
Why?
|
| Heterosexuality | 1 | 2013 | 20 | 0.100 |
Why?
|
| Social Marginalization | 1 | 2013 | 3 | 0.100 |
Why?
|
| Acquired Immunodeficiency Syndrome | 1 | 2013 | 68 | 0.100 |
Why?
|
| Trichomonas Vaginitis | 1 | 2013 | 1 | 0.100 |
Why?
|
| Parasitology | 1 | 2013 | 2 | 0.100 |
Why?
|
| Gonorrhea | 2 | 2010 | 24 | 0.100 |
Why?
|
| Chlamydia Infections | 2 | 2010 | 30 | 0.100 |
Why?
|
| Health Education | 1 | 2013 | 109 | 0.100 |
Why?
|
| Military Personnel | 1 | 2015 | 121 | 0.100 |
Why?
|
| Men's Health | 1 | 2012 | 5 | 0.090 |
Why?
|
| Self Efficacy | 1 | 2012 | 65 | 0.090 |
Why?
|
| Confidentiality | 1 | 2012 | 77 | 0.090 |
Why?
|
| Safe Sex | 1 | 2012 | 24 | 0.090 |
Why?
|
| Reproducibility of Results | 2 | 2016 | 2784 | 0.090 |
Why?
|
| Point-of-Care Systems | 1 | 2013 | 155 | 0.090 |
Why?
|
| Crime Victims | 1 | 2012 | 59 | 0.090 |
Why?
|
| Delivery of Health Care | 1 | 2016 | 480 | 0.080 |
Why?
|
| Hepatitis B | 1 | 2011 | 78 | 0.080 |
Why?
|
| Logistic Models | 5 | 2014 | 1275 | 0.080 |
Why?
|
| Longitudinal Studies | 2 | 2015 | 1284 | 0.080 |
Why?
|
| Violence | 1 | 2012 | 164 | 0.080 |
Why?
|
| Multivariate Analysis | 3 | 2014 | 1009 | 0.080 |
Why?
|
| Social Identification | 1 | 2010 | 29 | 0.080 |
Why?
|
| Cervix Uteri | 1 | 2010 | 73 | 0.080 |
Why?
|
| Attitude of Health Personnel | 1 | 2015 | 685 | 0.080 |
Why?
|
| Antibodies, Viral | 1 | 2011 | 338 | 0.070 |
Why?
|
| Self Disclosure | 1 | 2008 | 29 | 0.070 |
Why?
|
| Computers | 1 | 2008 | 102 | 0.070 |
Why?
|
| Computing Methodologies | 1 | 2008 | 8 | 0.070 |
Why?
|
| Stereotyping | 1 | 2008 | 21 | 0.070 |
Why?
|
| Health Status | 1 | 2010 | 385 | 0.070 |
Why?
|
| Truth Disclosure | 1 | 2008 | 75 | 0.070 |
Why?
|
| Permissiveness | 1 | 2007 | 1 | 0.070 |
Why?
|
| DNA, Protozoan | 1 | 2007 | 15 | 0.070 |
Why?
|
| Chlamydia trachomatis | 1 | 2007 | 15 | 0.070 |
Why?
|
| Neisseria gonorrhoeae | 1 | 2007 | 18 | 0.070 |
Why?
|
| Italy | 2 | 2003 | 113 | 0.060 |
Why?
|
| Gender Identity | 2 | 2018 | 59 | 0.060 |
Why?
|
| DNA, Bacterial | 1 | 2007 | 236 | 0.060 |
Why?
|
| Cohort Studies | 1 | 2013 | 3212 | 0.060 |
Why?
|
| Odds Ratio | 1 | 2007 | 726 | 0.060 |
Why?
|
| Commerce | 2 | 2015 | 29 | 0.060 |
Why?
|
| Premenopause | 1 | 2003 | 65 | 0.050 |
Why?
|
| Dyspareunia | 1 | 2003 | 23 | 0.050 |
Why?
|
| Postmenopause | 1 | 2003 | 109 | 0.050 |
Why?
|
| Prospective Studies | 1 | 2012 | 4823 | 0.050 |
Why?
|
| Polychlorinated Dibenzodioxins | 1 | 2002 | 4 | 0.050 |
Why?
|
| Dysmenorrhea | 1 | 2003 | 62 | 0.050 |
Why?
|
| Environmental Pollutants | 1 | 2002 | 67 | 0.040 |
Why?
|
| Menstrual Cycle | 1 | 2002 | 84 | 0.040 |
Why?
|
| Contact Tracing | 2 | 2014 | 29 | 0.040 |
Why?
|
| Environmental Exposure | 1 | 2002 | 405 | 0.040 |
Why?
|
| Baths | 1 | 2016 | 10 | 0.030 |
Why?
|
| Diagnostic Self Evaluation | 1 | 2016 | 14 | 0.030 |
Why?
|
| Afghan Campaign 2001- | 1 | 2015 | 5 | 0.030 |
Why?
|
| Iraq War, 2003-2011 | 1 | 2015 | 5 | 0.030 |
Why?
|
| Peru | 1 | 2015 | 28 | 0.030 |
Why?
|
| California | 1 | 2015 | 169 | 0.030 |
Why?
|
| RNA, Viral | 1 | 2014 | 288 | 0.020 |
Why?
|
| Social Conditions | 1 | 2012 | 8 | 0.020 |
Why?
|
| Multilevel Analysis | 1 | 2012 | 26 | 0.020 |
Why?
|
| Social Values | 1 | 2012 | 44 | 0.020 |
Why?
|
| New York City | 1 | 2012 | 75 | 0.020 |
Why?
|
| Seroepidemiologic Studies | 1 | 2011 | 58 | 0.020 |
Why?
|
| Propensity Score | 1 | 2012 | 213 | 0.020 |
Why?
|
| Hepatitis B virus | 1 | 2011 | 49 | 0.020 |
Why?
|
| Research Design | 1 | 2015 | 660 | 0.020 |
Why?
|
| Syphilis | 1 | 2011 | 38 | 0.020 |
Why?
|
| Population | 1 | 2010 | 36 | 0.020 |
Why?
|
| Epidemiologic Methods | 1 | 2010 | 60 | 0.020 |
Why?
|
| Social Desirability | 1 | 2010 | 12 | 0.020 |
Why?
|
| Social Change | 1 | 2010 | 9 | 0.020 |
Why?
|
| Likelihood Functions | 1 | 2010 | 258 | 0.020 |
Why?
|
| Immunoglobulin G | 1 | 2011 | 480 | 0.020 |
Why?
|
| Linear Models | 1 | 2010 | 424 | 0.020 |
Why?
|
| Trichomonas Infections | 1 | 2008 | 1 | 0.020 |
Why?
|
| Sensitivity and Specificity | 1 | 2013 | 1945 | 0.020 |
Why?
|
| Transportation | 1 | 2008 | 26 | 0.020 |
Why?
|
| Emigration and Immigration | 1 | 2008 | 50 | 0.020 |
Why?
|
| Bias | 1 | 2008 | 139 | 0.020 |
Why?
|
| Social Isolation | 1 | 2008 | 73 | 0.020 |
Why?
|
| Primary Health Care | 1 | 2011 | 395 | 0.020 |
Why?
|
| Animals | 1 | 2007 | 28894 | 0.020 |
Why?
|
| Adaptation, Psychological | 1 | 2008 | 190 | 0.020 |
Why?
|
| Chemical Industry | 1 | 2002 | 1 | 0.010 |
Why?
|
| Explosions | 1 | 2002 | 7 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2015 | 9711 | 0.010 |
Why?
|
| Biomarkers | 1 | 2008 | 2020 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 2002 | 4025 | 0.010 |
Why?
|
| Aged | 1 | 2012 | 21758 | 0.010 |
Why?
|